Introduction
Wnt was originally identified as an oncogene activated by the mouse mammary tumor virus in murine breast cancer (Nusse and Varmus, 1982) . The Wnt signaling pathway has been shown to play an essential role in early embryonic development (Micsenyi et al., 2004; Nelson and Nusse, 2004) . Wnt signals are transduced by the Frizzled (Fz) family of seven transmembrane domain receptors (Bhanot et al., 1996) , which subsequently activate the cytoplasmic protein Dishevelled and destabilize the complex formed by APC, Axin and glycogen synthesase kinase 3 (GSK3). Since APC/Axin/ GSK3 complex promotes phosphorylation and destabilization of b-catenin, the Wnt signaling leads to stabilization and nuclear translocation of b-catenin, which in turn forms a complex with TCF transcription factors to transcribe target genes. Constitutively activation of the Wnt signaling pathway by genetic alterations of APC, Axin1, and b-catenin genes has been observed in many human cancers including hepatoma (HCC) (Morin et al., 1997; Rubinfeld et al., 1997; de La Coste et al., 1998; Satoh et al., 2000) , emphasizing the long recognized connection between deregulation of normal development and cancer transformation (Cardigan and Nusse, 1997) . This relationship was further supported by a recent finding of c-myc oncogene as well as cyclin D1 as targets of the Wnt signaling (He et al., 1998; Sasaki et al., 2003) . The Dickkopf (Dkk) family comprises Dkk-1, Dkk-2, Dkk-3, Dkk-4, together with a unique Dkk-3-related protein termed Soggy (Sgy) (Krupnik et al., 1999; Bafico et al., 2001) . Human Dkk-1 and Dkk-4, but not Dkk-2, Dkk-3 or Sgy, have been found to be the inhibitors for Wnt signaling by binding to the transmembrane receptors Krm and LRP5/6, a corepressor of the Wnt/Fz receptor (Fedi et al., 1999; Krupnik et al., 1999; Brott and Sokol, 2002; Grotewold and Ruther, 2002; Mao et al., 2002) . Once Wnt signaling is suppressed by Dkk, b-catenin is phosphorylated and subsequently targeted for ubiquitination and degradation. It is, therefore, to speculate that whether Dkk proteins function as tumor suppressors. Indeed, Dkk-1 has been reported to function as a suppressor of HeLa cell transformation (Mikheev et al., 2004) . Overexpression of Dkk-1 in human hepatoblastomas and Wilm's tumors has been attributed to a negative feedback mechanism for the uncontrolled Wnt signaling (Wirths et al., 2003) . By contrast, Dkk-2 can both activate and inhibit Wnt/LRP6 signaling, which is regulated by Krm2 (Mao and Niehrs, 2003) . However, the biological role of Dkk-3 remains unclear.
To identify systemically potential tumor suppressor genes for tumorigenesis of human hepatoma, we have combined the methods of representational difference analysis and reverse northern blot analysis identifying genes significantly downregulated in hepatoma tissues (downregulated genes in hepatoma or DORGH genes). Of them, DORGH-1 was found to be the Dkk-3 gene. Herein, we report our studies on further examination of its expression in human hepatoma tissue and characterization of its product, Dkk-3/REIC, in regulation of cell proliferation and apoptosis, and in tumorigenecity both in vitro and in vivo.
Results
Expression of DORGH-1 (Dkk-3/REIC) in human hepatoma and in other human cancers To identify potential suppressor genes for tumor development of human hepatoma, we have combined the methods of representational difference analysis and reverse northern blot analysis identifying eight genes significantly downregulated in hepatoma tissues (DORGH-1 to -8 genes) (data not shown). We further confirmed the downregulation of DORGH-1 in HCC in 20 pairs of HCC and their corresponding non-HCC liver tissues using northern blot analysis ( Figure 1a ). The mRNA level of DORGH-1 was found to be downregulated in 11 HCC samples, while being upregulated in two HCC samples. We then used a human cancerprofiling array (BD Bioscience Clontech, Palo Alto, CA, USA) to analyse the differential expression of DORGH-1 in a variety of human cancers, and found that DORGH-1 was down-and upregulated in 29 and seven out of the 48 various human cancer tissues respectively, as compared to their counterparts of noncancerous tissues (Figure 1b ).
DORGH-1 gene was identical to the Dkk-3/REIC gene
We cloned the whole reading frame for the DORGH-1 cDNA from the liver of a patient with chronic B hepatitis. Sequence comparison revealed that its product contained 350 amino acids and was almost identical to that of Dkk-3/REIC (Figure 2a ). Amino-acid sequence analysis disclosed a signal peptide (amino acid 1-22) in its N-terminal and three potential N-linked glycosylation sites (at amino acid 96-99, 106-109 and 204-207) , suggestive of a secreted, N-glycosylated protein.
Dkk-3/REIC is an N-glycosylated protein with both cytosolic and secreted forms
We then subcloned the Dkk-3/REIC cDNA in-frame fused to an HA tag at its C-terminal [pMH(Dkk-3/ REIC)]. The expression of Dkk-3/REIC was thus assayed by using the anti-HA antibody. As shown in Figure 2b , a 55 kDa protein, which was much larger than the expected 40 kDa (including C-end HA tag), was seen in the lysate of the cells transfected with pMH(Dkk-3/REIC) (Lane 3), but not in the cell untransfected or transfected with the empty vector (Lanes 1 and 2, respectively). To examine whether Dkk-3/REIC was glycosylated, the cellular lysate positive for Dkk-3/REIC was treated with O-linked glycosidase, N-linked glycosidase and both with O-and N-linked glycosidases, respectively ( Figure 2c , Lanes 2, 3 and 4, respectively). The molecular weight was reduced as treated with N-linked glycosidase but no more reduced as treated additionally with O-linked glycosidase, indicative of N-glycosylation of the protein. We further examined whether the Dkk-3/REIC was secreted or not. A relatively smaller Dkk-3/REIC, about 50 kDa, was detected in the culture medium, which was smaller than that detected in cell lysate (Figure 2d , Lanes 1 and 2, respectively).
To inspect the subcellular distribution of the Dkk-3/ REIC detected in cell lysate, we used fluorescenceconjugated anti-HA antibodies to inspect the Dkk-3/ REIC in the transfected cells ( Figure 3) . As compared to the cells transfected with the enhanced green-fluorescence protein (EGFP) (Figure 3a and c) , much fewer cells were positive for Dkk-3/REIC, which was exclusively localized in the cytoplasm (Figure 3b and d) . Moreover, cells positive for Dkk-3/REIC presented with cytoplasm shrinking, membrane blebbing and nucleus condensation, which are characteristics of apoptosis.
Figure 1 (a) Northern blot analysis for the DORGH-1 (Dkk-3/ REIC) mRNA in hepatoma and their counterpart of nonhepatoma liver tissues. Of the total cellular RNA, 20 mg was extracted from human hepatoma tissues and their counterparts of noncancerous liver tissues and was electrophoresed on a 1.5% formaldehyde agarose gel followed by transferring onto a nylon membrane. The amount of input RNA for each sample was further normalized by the relatively equal amount of 28S RNA (data not shown). The negative (À) and positive ( þ ) controls were derived from Huh7 cells and from a liver tissue positive for the Dkk-3/RIEC mRNA, respectively. (b) Summary of the results of cancer-profiling array (BD Biosciences Clontech). Two-or more-fold difference between the tumor and counterpart nontumor pair was regarded as significant
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Apparently, Dkk-3/REIC was N-glycosylated and had two isoforms, the secreted and cytosolic forms.
Dkk-3/REIC suppresses cell proliferation in a cell-type and cell-density-dependent manner
To examine the effect of Dkk-3/REIC on cell proliferation, we transfected HeLa, Hep3B and Huh7 cells with either the empty vector or the pMH(Dkk-3/REIC), respectively. Ectopic expression of Dkk-3/REIC led to , respectively. (i) the Caspase 3 colometric assay. Caspase 3 activity was determined by the amount of its specific activity to convert DEVD-p-nitroaniline to p-nitroaniline (pNA) Liberated pNA was determined colometrically by absorbance at 405 nm. Cells after 48 h transfrection with pMH(Dkk-3/REIC) was subjected for this assay (Dkk-3/REIC). Cells irradiated with 50 mJ/cm 2 (UV), cells untransfected or transfected with empty vector were used as positive and negative controls, respectively. Treatment with Caspase 3 inhibitor in the cell lysate after receiving UV irradiation was used as an additional negative control (UV þ Inh) Dkk-3 functions as a tumor suppressor gene S-Y Hsieh et al suppression on cell proliferation (Figure 3e-g ). However, the suppression activity was found to be variable among different cell types. That is, it was most prominent in HeLa cells (Figure 3e ), but relatively less efficient in Huh7 cells (Figure 3f ) and least effective in Hep3B cells (Figure 3g ), although the endogenous Dkk-3/REIC gene expression was reduced in all of the three human cancer cell lines (data not shown; Tsuji et al., 2001) . Furthermore, the suppression activity was found to be related to the density of the cultured cells, that is, the suppression was attenuated as the cell density increased (Figure 3h ).
As mentioned above, the most striking features of cells with ectopic expression of Dkk-3/REIC were cell shrinking, membrane blebbing and nucleus condensation, which were characteristics for cell apoptosis (Figure 3b and d vs 3a and c) . To confirm that Dkk-3/ REIC induced apoptosis, we assayed the activity of the Caspase 3 and found that Caspase 3 activity was remarkably increased after 18 hours of transduction of Dkk-3/REIC (Figure 3i) . Therefore, the suppression of cell proliferation was primarily due to induction of cell apoptosis by Dkk-3/REIC.
Dkk-3/REIC suppresses tumor growth in nude mice
To examine whether Dkk-3/REIC suppressed tumor growth in vivo, we constructed cell lines in which the expression of Dkk-3/REIC could be induced as Doxycycline removed from the medium. As shown in Figure 4a , tumors transduced with Dkk-3/REIC grew much slower than those not transduced with Dkk-3/ REIC. The relative expression of Dkk-3/REIC in the tumors derived from the parental tumor cells and from two clones of Dkk-3/REIC transduced cell lines was further confirmed by RT-PCR and immunoblotting analysis (Figure 4b ). These findings indicated that Dkk-3/REIC suppressed tumor growth in vivo. In addition, cells transduced with Dkk-3/REIC had a much lower capacity for colony formation in culture assays than did the parental cells (data not shown).
Loss of heterozygosity plays a minor role in loss of expression of Dkk-3/REIC in human hepatoma
To gain insight into the mechanisms causing loss of function for Dkk-3/REIC in hepatoma, loss of heterozygosity (LOH) was analysed at the 11p15.2 region (Dkk-3/REIC locus) using one single-nucleotide polymorphism and two microsatellite markers in 20 pairs of hepatoma and matched noncancerous liver tissues. The results showed allelic loss only in one of the 15 informative cases ( Figure 5 ).
Discussion
Recently, Dkk-3 has been identified as a downregulated gene in a variety of human immortalized and tumorderived cell lines named as 'reduced expression in immortalized cells', REIC, by Tsuji et al. (2000) and in different types of human cancers (Tsuji et al., 2001; Kurose et al., 2004) . Herein, we report our independent studies identifying Dkk-3/REIC as a downregulated gene in human hepatoma via a genome-wide screening. We also found that Dkk-3/REIC was downregulated in other human cancers, especially in the kidney, urinary bladder, pancreas and lung, indicative of a significant role of Dkk-3/REIC in suppression of human cancer development. Downregulation of Dkk-3/REIC in human cancers was attributable to the promoter hypermethylation in human cancer cells (Kobayashi et al., 2002) . On the other hand, we only detected the loss of heterozygosity at Dkk-3/REIC in one of our hepatoma cases (6.7% of 15 informative cases). Taken together, these findings suggest the significance of loss of the function of Dkk-3/REIC primarily via an epigenetic mechanism in human carcinogenesis. We further provided circumstantial evidence to support that Dkk-3/REIC could function as a suppressor of tumor growth. First, we demonstrated that ectopic expression of Dkk-3/REIC led to cell apoptosis so as to suppress cell growth. Second, constitutive expression of Dkk-3/REIC inhibited colony formation in cultured assays. Third, transduction of Dkk-3/REIC suppresses tumor growth in inoculated nude mice.
Inhibitory activity on cell growth by Dkk-3/REIC had also been reported in lung cancer cells before (Tsuji et al., 2001) . Herein, we found the inhibitory activity was primarily caused by promotion of cell apoptosis, although it could also be due to suppression on cell cycle progression by Dkk-3/REIC (Tsuji et al., 2001) . Of interest, in our studies the growth inhibitory activity of Dkk-3/REIC was found to be cell type related (more prominent in HeLa cells than in Huh7 and Hep3B cells) and cell-density dependent (the activity was attenuated as cell density increased). Indeed, b-catenin, the key element of Wnt signaling pathway, also functions as a component of the cadherin complex in controlling cellcell and cell-matrix interactions (Nusse and Varmus, 1992) . Moreover, cadherin's function is critical in normal development, and alterations in cadherin's function have been implicated in tumorigenesis (Wheelock and Johnson, 2003) . It is, therefore, plausible to speculate that the inhibitory activity on cell growth of Dkk-3/REIC may be related to this or a similar cell-cell or cell-matrix interaction and, probably, its loss of function leads to perturbation of regulation of cell proliferation and death so as to contribute to tumorigenesis. However, little has been known even about the biological function of Dkk-3/REIC. The study identifies the cellular partners interacting with Dkk-3/REIC and the signaling pathways that Dkk-3/REIC is involved in is currently ongoing.
In summary, we report the downregulation of Dkk-3/ REIC in human hepatoma and other human cancers as well. Ectopic expression of Dkk-3/REIC led to cell apoptosis, and inhibition of cell growth in vitro as well as tumor growth in vivo. Our findings, taken together with others' studies, highlight a potential role of Dkk-3/ REIC in maintaining the tissue homeostasis for cell proliferation vs death and cell differentiation vs tumor transformation.
Materials and methods

Hepatoma cell lines and liver tissue
Human hepatoma cell lines, Hep3B and Huh7, and human cervical epithelium cancer cell line, HeLa cells, were obtained from the American Tissue Culture Collection (Manassas, VA, USA). Hepatoma and the corresponding noncancerous liver tissues were obtained from 20 patients, who had liver surgery at Chang Gung Memorial Hospital. Diagnoses of HCC and matched nonhepatoma liver tissues were based on histopathological findings. The Ethics and Science Committee of Chang Gung Memorial Hospital approved specimen collection procedures and informed consent was obtained from each subject or subject's family.
cDNA clone and sequencing
A cDNA fragment with about 350 bp was isolated after the third round of subtractive hybridization (representation difference analysis) using the protocol as described before (Lisitsyn et al., 1993) . Sequence matching performed by screening the BLAST-Database (http://ncbilnlm.nih.gov/ BLAST) revealed that it was matched to a region within the newly identified cDNA of Dkk-3/REIC gene (GenBank AB034203). The whole reading-frame for the Dkk-3/REIC cDNA was cloned using RT-PCR from a cDNA library derived from the nontumor part of the liver of a patient with chronic B hepatitis. The cloning and sequencing analyses were performed as described before (Hsieh et al., 2003) and its sequences had been deposited in GenBank (AY587550).
LOH analysis
DNA was prepared from 20 pairs of hepatoma and matched nonhepatoma liver tissues and subjected to LOH screening at the 11p15.2 (Dkk-3/REIC) region using the two microsatellite markers, D11P152 (5 0 -GCCACAATATAGAGAGACCC-CAT-3 0 and 5 0 -GCTTTGTGAGCATGTGCAGCT-3 0 , designed by SYH) and D11S1981 (www.ncbi.nih.gov/genome/ sts/) and one single-nucleotide polymorphism marker, G19726 (www.ncbi.nlm.nih.gov/genome/sts/). PCR was performed using a 32 P end-labeled primer, and the amplified fragments were separated by electrophoresis in a 6% denaturing polyacrylamide gel as described elsewhere (Gao et al., 2004) . LOH was determined by visual evaluation, which compared the allele bands from tumors and the corresponding nontumor liver tissues. At least a 50% reduction in the relative intensity of one allele compared with the nontumor control was regarded as LOH.
Construction of Dkk-3 expression vector
The cDNA for DORGH-1 (Dkk-3/REIC) was subcloned into the pMH mammalian expression vector (Roche Applied Science, Mannheim, Germany) in which a 9-amino acid tag derived from an epitope of the hemagglutinin of influenza virus was in-frame fused at the C-terminal of Dkk-3/REIC. To control the expression of Dkk-3/REIC in the transduction cells, we also subcloned the Dkk-3/REIC cDNA into the vector pTRE2 in which the expression of inserted genes was regulated by the presence or absence of tetracycline/doxycycline (BD Bioscience Clontech). The resulted clones, pMH(Dkk-3/REIC) and pTRE2(Dkk-3/REIC), were confirmed by sequencing analysis (Hsieh et al., 2003) .
Northern blot analysis
Total cellular RNA was extracted from liver tissue by using the one-step acid-phenol method described before (Lin et al., 2001) . Of the total cellular RNA, 20 mg was separated on a 1.5% formaldehyde agarose gel followed by transferring onto a nylon membrane (ZetaProbe, BioRad, Hercules, CA, USA). The amount of input RNA for each sample was further normalized by that of the 28S RNA (data not shown). The membrane was prehybridized and then hybridized in 32 Plabeled RNA probe overnight at 651C. The probe was prepared by transcribing the complementary RNA using an in vitro transcription kit (Riboprobe system, Promega, Madison, WI, USA) in accordance with the manufacturer's instructions. The radioactivity for each target signal was quantified and analysed by a bioimage analyzer.
Cell proliferation
To profile the cell proliferation curve, we seeded 1 Â 10 5 cells onto each 35-mm dish. After 24 h, cells were transfected with 400 ng/well of plasmids [pMH(Dkk-3/REIC) vs pMH vector as the control] using Effectene Transfection Reagent (QIA-GEN Inc., Valencia, CA, USA) in accordance with the manufacturer's instructions. The viable cell numbers, which were determined by exclusion of the cells stained by trypan blue in a hemocytometer, were counted at 36, 60 and 84 h after transfection. The studies were conducted using HeLa, Hep3B and Huh7 cells, respectively. Each study was conducted at least twice in triplicate.
Immunoblot analysis and protein glycosylation assay
Cell or tumor extract was prepared by homogenizing and then lysing cells in a buffer containing 50 mM Tris-HCl pH 8.0, 120 mM NaCl, 0.5% NP-40, 0.25% Na Deoxycholate, 1 mM DTT, 2 mg/ml aprotinin and 2 mg/ml leupeptin. Of the cell lysate, 40 mg was subjected to electrophoresis followed by immunoblotting analysis using antibodies against HA epitope (Anti-HA-Peroxidase, Roche Applied Science, Mannheim, Germany) or the polyclonal antibodies raised against Dkk-3. To detect Dkk-3/REIC in the culture medium, cells had been incubated in the serum-free medium for 24 h before harvest. Medium proteins were precipitated, resuspended in the lysis buffer and then analysed with immunoblotting assays. To determine whether Dkk-3/REIC was glycosylated, 40 mg cell lysate was treated with 2 mU O-glycosidase or 2 U Nglycosidase F, or both before immunoblotting analysis in accordance with the manufacturer's instruction (Roche Applied Science, Mannheim, Germany).
Immunofluorescence staining
To inspect directly the subcellular distribution of the Dkk-3/ REIC, 48 h after transfection, cells were fixed in acetone/ methanol (1:1 v/v) solution at À201C for 5 min. After washing twice with PBS, a fluorescence-conjugated mouse monoclonal anti-HA antibody (Roche Applied Science, Mannheim, Germany) was used for detection of the HA-tagged Dkk-3/ REIC. As a control, we transfected cells with the plasmid expressing EGFP. The expressed Dkk-3/REIC or EGFP was inspected using fluorescence microscopy with fluorescence isothiocyanate (FITC) filter.
UV irradiation and apoptosis assays
To assay cell apoptosis upon ectopic expression of Dkk-3/ REIC, we transfected HeLa cells with pMH(Dkk-3/REIC) and pMH vector as a control. Meanwhile we also used cells untransfected and cells irradiated with UV as negative and positive controls, respectively. For the UV irradiation control, cells were irradiated with 50 mJ/cm 2 of UVB (290-320 nm) 3 h before harvest. Cell apoptosis was determined by morphological characteristics (cell shrinkage, membrane blebbing and nucleus condensation) and Caspase 3 assays. To assay the Caspase 3 activity, we used the ApoAlert Caspase-3 Colorimetric Assay kit (BD Bioscience Clontech). Briefly, 48 h after transfection, 2 Â 10 6 cells were lysed in 50 ml of lysis buffer. Following incubation on ice for 10 min, the lysate was mixed with reaction buffer and the Caspase 3 substrate (DEVD-pnitroaniline) and incubated at 371C for another hour. The Caspase 3 activity was determined by the colorimetric detection at 405 nm in a microtitering plate reader.
In vivo tumorigenicity assay
To construct cell lines in which the expression of Dkk-3/REIC could be regulated, we subcloned the Dkk-3/REIC cDNA under the regulation by the presence or absence of doxycycline (the Tet-off gene expression system, BD Bioscience Clontech). The resultant plasmid was then transfected into a HeLa cell line constitutively expressing the tetracycline-controlled transcriptional activator (HeLa tet-off cells, BD Bioscience Clontech). After selection with G418, cell clones inducibly expressing Dkk-3/REIC by removing doxycycline from the medium were subcloned and confirmed by RT-PCR assays. Two clones were then used for the tumorigenicity assays in vivo. We used male BALB/c athymic nude mice (the National Experimental Animal Center, National Science Council, Taipei, Taiwan). Animal care, human use and treatment of mice were in strict compliance with the guidelines described in the 'Animal Care and Use Committee of the Chang Gung Memorial Hospital, TAIWAN' and the 'Guide for the Care and Use of Laboratory Animals' prepared by the National Academy of Sciences, NIH, USA, 1985. Animals 8 weeks old received unilateral injection into the thoracodorsal subcutaneous tissue of 5 Â 10 6 cells. The maximal tumor diameter was determined by caliber measurements once a week up to seventh week after inoculation. The tumors were then excised and dissected for pathological studies and immunoblotting analysis.
